Eli Lilly

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Eli Lilly 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About LLY

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. 

CEO
David A. Ricks
CEODavid A. Ricks
Employees
50,000
Employees50,000
Headquarters
Indianapolis, Indiana
HeadquartersIndianapolis, Indiana
Founded
1876
Founded1876
Employees
50,000
Employees50,000

LLY Key Statistics

Market cap
1.21T
Market cap1.21T
Price-Earnings ratio
43.56
Price-Earnings ratio43.56
Dividend yield
0.52%
Dividend yield0.52%
Average volume
2.50M
Average volume2.50M
High today
$1,300.58
High today$1,300.58
Low today
$1,260.34
Low today$1,260.34
Open price
$1,265.05
Open price$1,265.05
Volume
2.03M
Volume2.03M
52 Week high
$1,321.21
52 Week high$1,321.21
52 Week low
$809.63
52 Week low$809.63

Stock Snapshot

With a market cap of 1.21T, Eli Lilly(LLY) trades at $1,299.34. The stock has a price-to-earnings ratio of 43.56 and currently yields dividends of 0.52%.

During the trading session on 2026-10-28, Eli Lilly(LLY) shares reached a daily high of $1,300.58 and a low of $1,260.34. At a current price of $1,299.34, the stock is +3.1% higher than the low and still -0.1% under the high.

Trading activity shows a volume of 2.03M, compared to an average daily volume of 2.5M.

The stock's 52-week range extends from a low of $809.63 to a high of $1,321.21.

The stock's 52-week range extends from a low of $809.63 to a high of $1,321.21.

LLY News

Benzinga 46m
Amazon, Eli Lilly On Deck Thursday As AWS Growth, Drug Demand Face Test - Benzinga

...

Amazon, Eli Lilly On Deck Thursday As AWS Growth, Drug Demand Face Test - Benzinga
TipRanks 4h
Eli Lilly’s Head of International Business Retires

Pharmaceutical giant Eli Lilly (LLY) has announced that Patrik Jonsson, executive vice president and president of the company’s ‌international business, will re...

Seeking Alpha 4h
Pharma giants Merck, Eli Lilly face earnings health check

Pharmaceutical giants Merck (MRK) and Eli Lilly (LLY) are scheduled to report third-quarter results on October 29, with analysts expecting a year-on-year earnin...

Pharma giants Merck, Eli Lilly face earnings health check

Analyst ratings

85%

of 33 ratings
Buy
84.8%
Hold
9.1%
Sell
6.1%

More LLY News

Investor's Business Daily 6h
Eli Lilly's Next-Gen Obesity Drug Trounces Ozempic In Head-To-Head Test

Technology Eli Lilly's Next-Gen Obesity Drug Trounces Ozempic In Head-To-Head Test Licensing Eli Lilly's (LLY) next-generation weight-loss drug, retatrutide, tr...

Eli Lilly's Next-Gen Obesity Drug Trounces Ozempic In Head-To-Head Test
Zacks 7h
How Are LLY's Neuroscience and Immunology Drugs Poised Ahead of Q3?

Eli Lilly’s (LLY Quick QuoteLLY - Free Report) portfolio is overwhelmingly driven by its popular GLP-1 medicines, Mounjaro and Zepbound. However, Neurosci...

How Are LLY's Neuroscience and Immunology Drugs Poised Ahead of Q3?
Benzinga 7h
Eli Lilly Says Retatrutide Delivers More Than Double Ozempic’s Weight Loss in Late-Stage Diabetes Trial

Eli Lilly and Company (NYSE: LLY) said its investigational drug retatrutide delivered "more than double the weight loss of the highest approved dose of Ozempic,...

Eli Lilly Says Retatrutide Delivers More Than Double Ozempic’s Weight Loss in Late-Stage Diabetes Trial
Investor's Business Daily 8h
Stock Market Today: Dow Falls Ahead Of Rate Decision, Warsh Comments; Robinhood Plunges (Live Coverage)

These 7 Stocks Are Analyst Favorites For Magnificent Earnings Growth; Lilly, Amazon Earnings Ahead 10/28/2026 Among the best stocks in earnings performance, hi...

Stock Market Today: Dow Falls Ahead Of Rate Decision, Warsh Comments; Robinhood Plunges (Live Coverage)
Simply Wall St 8h
Eli Lilly Keeps Obesity Ads Live As Court Rules And AI Program Launches

Eli Lilly (NYSE: LLY) kept its obesity drug ads running after a U.S. federal court rejected Novo Nordisk's request for an injunction. Judges declined Novo Nord...

Benzinga 10h
Top Wall Street Forecasters Revamp Eli Lilly Expectations Ahead Of Q3 Earnings

Eli Lilly and Company (NYSE:LLY) will release its third quarter earnings report before the opening bell on Thursday, Oct. 29. Analysts expect the Indianapolis,...

Top Wall Street Forecasters Revamp Eli Lilly Expectations Ahead Of Q3 Earnings
Zacks 13h
The Zacks Analyst Blog Highlights Eli Lilly, Novartis, Johnson & Johnson and AbbVie

Chicago, IL – October 28, 2026 – Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the l...

The Zacks Analyst Blog Highlights Eli Lilly, Novartis, Johnson & Johnson and AbbVie

People also own

Based on the portfolios of people who own LLY. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.